Trial Search Results

Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant

The aim of this study is to evaluate whether peri-transplant administration of a drug named aminophylline to children undergoing a kidney transplant from deceased donors improves early graft function and also projects on long term graft function.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Aminophylline
  • Other: Theophylline drug levels
  • Drug: Placebo

Phase:

N/A

Eligibility


Inclusion Criteria:

   1. Pediatric kidney transplant recipients less than 21 years of age

   2. Patients undergoing deceased donor (DD) kidney transplants

Exclusion Criteria:

   1. Known history of non-sinus tachycardia

   2. Multiple organ transplants recipients

   3. Severe liver dysfunction

   4. graft was placed on pump after harvesting

Ages Eligible for Study

1 Year - 21 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Vivian Shih, MD
650-723-7903
Recruiting